Live Quote · NASDAQTSVTHealthcare· Biotechnology

2seventy bio, Inc.

$5.00 0.00%(+$0.00)
TickerSpark Score
65/100
Solid
60
Valuation
35
Profitability
55
Growth
76
Health
100
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TSVT research report →

52-Week Range90% of range
Low
$2.29
Current
$5.00
High
$5.30
Company Overviewwww.2seventybio.com

About the company

2seventy bio, Inc. operates as a biotechnology firm specializing in cell and gene therapies, with a primary mission to discover, develop, and commercialize advanced cancer treatments within the U. S.

CEO
William D. Baird III,
IPO
2021
Employees
65
HQ
Cambridge, MA, US

Price Chart

+12.87% · this period
$5.21$3.75$2.30May 09Nov 07May 12
Valuation
Market Cap
$266.14M
P/E
-4.55
P/S
7.03
P/B
1.24
EV/EBITDA
-4.46
Div Yield
0.00%
Profitability
Gross Margin
40.41%
Op Margin
-304.87%
Net Margin
-151.20%
ROE
-24.56%
ROIC
-24.45%
Growth & Income
Revenue
$37.86M · -62.28%
Net Income
$-57,247,000 · 73.69%
EPS
$-1.10 · 75.11%
Op Income
$-115,430,000
FCF YoY
52.58%
Performance & Tape
52W High
$5.30
52W Low
$2.29
50D MA
$4.97
200D MA
$4.05
Beta
1.05
Avg Volume
1.46M

Get TickerSpark's AI analysis on TSVT

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
May 13, 25Glickman Sarah JSsell12,050
May 13, 25Glickman Sarah JSsell24,100
May 13, 25Glickman Sarah JSother15,602
May 13, 25Casdin Capital, LLCother2,000,000
May 13, 25Casdin Capital, LLCsell33,400
May 13, 25Casdin Capital, LLCsell12,050
May 13, 25Leschly Nicksell335,964
May 13, 25Leschly Nicksell469,000
May 13, 25Leschly Nickother41,000
May 13, 25Eatwell Victoriasell401,111
Coverage · TSVT

Our TSVT coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on TSVT yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate TSVT report →
Internal Compare

Similar companies

Peers in the same neighborhood.